Ensure Your Pradaxa Patients Don't Need the New Antidote, Praxbind

You'll hear buzz about the new IV med, Praxbind (PRAKS-bynd, idarucizumab) to reverse life-threatening bleeding caused by Pradaxa.

This is a big deal. We know that vitamin K reverses bleeding due to warfarin...but it doesn't work for the newer oral anticoagulants such as Pradaxa (dabigatran).

Up until now, managing bleeding with Pradaxa and other newer anticoagulants has been limited to stopping the drug, supportive care, and using blood products in the hospital.

Practical advice for a better career, with unlimited access to CE

Pharmacy Technician's Letter Canada includes:

  • 12 issues every year, with brief articles about new meds and hot topics
  • 200+ CE courses, including the popular CE-in-the-Letter
  • Helpful, in-depth Technician Tutorials
  • Access to the entire archive

Already a subscriber? Log in

Volume pricing available. Get a quote